0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2019
Published Date: March 2019
|
Report Code: DELV-Pipe-123
Home | Market Reports | Health | Aging & Geriatrics
Dementia Associated With Alzheimers Disease Pipeline Insight 2019

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2019

Code: DELV-Pipe-123
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

"Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dementia Associated With Alzheimer's Disease development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Dementia Associated With Alzheimer's Disease
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Dementia Associated With Alzheimer's Disease
The report assesses the active Dementia Associated With Alzheimer's Disease pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Dementia Associated With Alzheimer's Disease
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Dementia Associated With Alzheimer's Disease
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Dementia Associated With Alzheimer's Disease
• The report also covers the dormant and discontinued pipeline projects related to the Dementia Associated With Alzheimer's Disease

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Dementia Associated With Alzheimer's Disease to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Dementia Associated With Alzheimer's Disease therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1. Report Introduction
2. Dementia Associated With Alzheimer's Disease Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Dementia Associated With Alzheimer's Disease
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

LIST OF TABLES :

Table 1: Total Products for Dementia Associated With Alzheimer's Disease
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

LIST OF FIGURES :

Figure 1: Total Products for Dementia Associated With Alzheimer's Disease
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$1250
This license allows only one user to access the PDF.

Electronic (PDF)
$2500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$4000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global Long Term Care Market Size Status and Forecast 2021 2027
Global Long-Term Care Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6C6419
Mon Jul 19 00:00:00 UTC 2021

Add to Cart

Global Alzheimer s Disease Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Alzheimer's Disease Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Early to Moderate Stages is the key application which covers over 55 shares.Market Analysis and Insights Global Alzheimers Disease Drug MarketIn 2020 the global Alzheimers Disease Drug market size was US 3539 million and it is expected to reach US 3956.1 million by the end of 2027 with a CAGR of 1.5 during 20212027.Global Alzheimers Diseas.

120 Pages
Type: Report
Code: QYRE-Auto-1529
Mon Jul 19 00:00:00 UTC 2021

Add to Cart

Global Alzheimers and Parkinsons Diseases Market Size Status and Forecast 2021 2027
Global Alzheimers and Parkinsons Diseases Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-11A6128
Sat Jul 17 00:00:00 UTC 2021

Add to Cart

Global Familial Amyloid Polyneuropathy Market Size Status and Forecast 2021 2027
Global Familial Amyloid Polyneuropathy Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-36Z6038
Fri Jul 16 00:00:00 UTC 2021

Add to Cart